Variant position: 389 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 477 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human NSAFNPIIYCRSPDFRKAFQ RLLCCARRAARRRHATHGDRP
Rhesus macaque NSAFNPIIYCRSPDFRNAFQ RLLCCARRAARRRHAAHGDRP
Mouse NSAFNPIIYCRSPDFRKAFQ RLLCCARRAACRRRAAHGDRP
Rat NSAFNPIIYCRSPDFRKAFQ RLLCCARRAACRRRAAHGDRP
Pig NSAFNPIIYCRSPDFRKAFQ RLLCCARRVARGSCAAAGDGP
Bovine NSAFNPIIYCRSPDFRKAFQ RLLCCARRAACGSHAAAGDPP
Sheep NSAFNPIIYCRSPDFRKAFQ RLLCCARRAACGSHGAAGDPP
Cat NSAFNPIIYCRSPDFRKAFQ RLLCFARRAARGGHAAAGDRP
Xenopus laevis NSAFNPIIYCRSPDFRKAFK RLLCCPKKADRHLHTT-GELS
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 477 Beta-1 adrenergic receptor
378 – 477 Cytoplasmic
392 – 392 S-palmitoyl cysteine
SeattleSNPs variation discovery resource;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS GLY-49; GLY-389 AND LEU-389;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.